94385 ⎘
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
Sub-classes:TRICYCLIC SKELETON COMPOUND AND USE THEREOF IN PREPARATION OF ANTITUMOR DRUG
#2MODULATORS OF FSHR AND USES THEREOF
#3NOVEL GPX4 INHIBITORS AND USES THEREOF
#4METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
#5RXFP1 AGONISTS
#6THERAPEUTIC COMPOUNDS
#7PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA
#8NOVEL PYRAZOLE DERIVATIVES
#9Methods and intermediates for preparing therapeutic compounds
#10INDENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION
#11CYCLOOCTYNES FOR CLICK CHEMISTRY
#12INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF
#13Pyrazole derivatives
#14INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
#15Pyrazole derivatives with anticancer activity
#16Inhibitors of the Notch transcriptional activation complex kinase (“NACK”) and methods for use of the same
#17CRF RECEPTOR ANTAGONISTS AND METHODS OF USE
#18Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#19BICYCLIC SULFONES AND SULFOXIDES AND METHODS OF USE THEREOF
#20INDENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION
#21Cyclooctynes for click chemistry
#22Indene derivatives useful in treating pain and inflammation
#23CANNABINOID RECEPTOR MODULATORS
#24Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#25Cannabinoid receptor modulators
#26Orai Channel Inhibitors
#27Benzoindazolone compound and intermediate thereof
#28Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne
#29Methods and intermediates for preparing therapeutic compounds
#30PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#31Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
#32ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS
#33COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS
#34Cannabinoid receptor modulators
#35Inhibitors of the notch transcriptional activation complex kinase (“NACK”) and methods for use of the same
#36Indene derivatives useful in treating pain and inflammation
#37Indene derivatives useful in treating pain and inflammation
#38Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#39Methods and intermediates for preparing therapeutic compounds
#40Aromatic derivative, preparation method for same, and medical applications thereof
#41Therapeutic compounds
#426,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
#43Compositions and methods for modulating farnesoid X receptors
#44Substituted heterocycles for targeting Hsp90
#45Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#46Spiroheptane salicylamides and related compounds as inhibitors of ROCK
#47Benzene, Pyridine, and Pyridazine Derivatives
#48CANNABINOID RECEPTOR MODULATORS
#49PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#50Cannabinoid receptor modulators
#51Methods and intermediates for preparing therapeutic compounds
#52Tricyclic rho kinase inhibitors
#53Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#54Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#55INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES
#566,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
#57IMINOSYDNONE DERIVATIVES FOR CONJUGATION AND RELEASE OF COMPOUNDS OF INTEREST
#58Bicyclic sulfones and sulfoxides and methods of use thereof
#59Medicament for liver regeneration and for treatment of liver failure
#60MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
#61Histone deacetylase inhibitors and compositions and methods of use thereof
#62Compositions and methods for modulating farnesoid X receptors
#63Heterocycle and carbocycle derivatives having TRKA inhibitory activity
#64Substituted heterocycles for targeting HSP90
#65Therapeutic compounds
#66CANNABINOID RECEPTOR MODULATORS
#67Pyrazolone derivatives as nitroxyl donors
#68CANNABINOID RECEPTOR MODULATORS
#69PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS
#70SHIP1 MODULATORS AND METHODS RELATED THERETO
#715-HT2 antagonists
#72Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
#73Organic electroluminescent materials and devices
#74PYRAZOLONE COMPOUNDS AND USES THEREOF
#75Therapeutic compounds
#76Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#77Pyrazole compounds as nitrification inhibitors
#78Substituted 6-aminopurines for targeting HSP90
#79Substituted pyrazolylpyrazole derivative and use of same as herbicide
#80SHIP1 modulators and methods related thereto
#81Organic compounds
#82TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS
#83Design, synthesis, and biological evaluation of 1-methyl-1, 4-dihyrdoindeno[1,2-C]pyrazole analogues as potential anticaner agents targeting tubulin colchicine binding site
#84Pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#85BTK inhibitor
#86Compositions and methods for modulating farnesoid X receptors
#876,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
#88SHIP1 MODULATORS AND METHODS RELATED THERETO
#89Pyrazolone compounds and uses thereof
#90Cannabinoid receptor modulators
#91Histone deacetylase inhibitors and compositions and methods of use thereof
#92SYDNONE DERIVATIVES FOR CONJUGATION OF COMPOUNDS OF INTEREST
#93Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
#94Therapeutic compounds
#95Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#96Compositions and methods for modulating farnesoid X receptors
#97Cyclohexyl sulfone RORγ modulators
#98Fused bicyclic isoxazolines as inhibitors of cholesterol ester transfer protein
#99N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#100Small molecules to enhance P53 activity
#1011,3-Disubstituted cyclopentane derivatives
#102Trizol-1-OL analogs anti-retroviral latency drugs
#103Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#104Indazolyl- and indolyl-benzamide derivatives
#105Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#106SHIP1 modulators and methods related thereto
#107Medicament for liver regeneration and for treatment of liver failure
#108Glucagon receptor modulators
#109Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#110Substituted indazoles for targeting Hsp90
#111Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#112Estrogen receptor modulators and uses thereof
#113Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HTantagonists
#114Substituted 4,5-dihydro-2H-benzo[]indazole-9-carboxylates for the treatment of diabetes and related disorders
#115Glucagon receptor modulators
#116Pharmaceutical compounds
#117Benzene, pyridine, and pyridazine derivatives
#118SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
#119Pyrazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#120Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#121Heterocyclic nuclear hormone receptor modulators
#122Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#123Cyclopentylpyrazoles as N-type calcium channel blockers
#124Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HTantagonists
#125Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
#126Glucagon receptor modulators
#127NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS
#1281-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
#129Cannabinoid receptor modulators
#130TRICYCLIC NECROSTATIN COMPOUNDS
#131BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES
#132Synthesis of substituted pyrazoline carboxamidine derivatives
#133PHARMACEUTICAL COMPOUNDS
#1341-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
#135Aldosterone synthase inhibitor
#136Cyclohexyl amide derivatives as CRF receptor antagonists
#137Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
#138Nuclear Hormone Receptor Modulators
#1392-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
#140Tricyclic heterocyclic compounds
#141Cannabinoid receptor modulators
#142Glucagon receptor modulators
#143Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
#144Cycloalkylphenyl substituted cyclic ketoenols
#145Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
#146INDAZOLE DERIVATIVES AS ADENOSINE MONOPHOSPHATE DEAMINASE (AMPD) INHIBITORS FOR USE IN DIABETES AND RELATED DISEASES OF METABOLIC SYNDROME
#1472H or 3H-benzo[E]indazol-1-YL carbamate derivatives, the preparation and therapeutic use thereof
#148HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
#149Polymerizable fullerene derivative and their use in organic photovoltaic cells
#150PYRAZOLINE COMPOUNDS
#151BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE
#152Spirocyclic nitriles as protease inhibitors
#153Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
#154SELECTIVE INHIBITORS OF C-JUN N-TERMINAL KINASE
#155TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS
#156Bicyclic compound
#157Cyclopentyl- and cycloheptylpyrazoles
#158PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#159Pyrazole Derivatives as Kinase Inhibitors
#160Benzene, pyridine, and pyridazine derivatives
#161Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
#162Pyrazoles for the treatment of obesity and other CNS disorders
#163Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
#164PYRROLE AND PYRAZOLE DAAO INHIBITORS
#1651-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
#166Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HTantagonists
#167Benzene, pyridine, and pyridazine derivatives
#168Dihydrobenzoindazoles
#169Hexahydrocyclopentyl[]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
#170HEXAHYDRO-CYCLOOCTYL PYRAZOLE CANNABINOID MODULATORS
#1711-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
#1722-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligands
#173INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT
#174NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#175PYRAZOLINE COMPOUNDS
#176Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
#177Fused heterocyclic compounds as inhibitors of potassium channel function
#178Hexahydro-cyclooctyl pyrazole cannabinoid modulators
#179PROCESS FOR MAKING GLUCOCORTICOID RECEPTOR LIGANDS
#180PHARMACEUTICAL COMPOSITIONS
#181PHARMACEUTICAL COMPOUNDS
#182Tricyclic necrostatin compounds
#183Estrogen receptor modulators
#184Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HTantagonists
#185Pyrrole and pyrazole DAAO inhibitors
#186PYRAZOLE COMPOUND
#187Tricyclic compound and pharmaceutical use thereof
#188Pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#189Cycloalkylphenyl substituted cyclic ketoenols
#190Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
#191Spirocyclic nitriles as protease inhibitors
#192FUSED PYRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF
#193PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRAZOLES
#194METHOD FOR TREATING CB2 RECEPTOR MEDIATED PAIN
#195Hexahydro-cycloheptapyrazole cannabinoid modulators
#196Pyrrole and pyrazole DAAO inhibitors
#197Benzene, pyridine, and pyridazine derivatives
#1982H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
#199Methods, compounds and compositions with genotype selective anticancer activity
#200Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
#201Pyrazole derivatives as kinase inhibitors
#202Octahydropentalene-Substituted Pyrazoline Derivatives, Their Prepartion and Use as Medicaments
#203Substituted bicyclic derivatives and use thereof
#204Coloring composition comprising at least one azomethine compound with a pyrazolinone unit
#205Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HTantagonists
#206Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
#207Non-nucleoside reverse transcriptase inhibitors
#208Azepane- or Azocane-Substituted Pyrazoline Derivatives, Their Preparation and Use as Medicaments
#209Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
#210N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors
#211NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION
#212Pyrazoline compounds
#213Benzene, Pyridine, and Pyridazine Derivatives
#214Hexahydro-cyclooctyl pyrazole cannabinoid modulators
#2151H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
#216Hexahydro-cycloheptapyrazole cannabinoid modulators
#217Substituted thioacetamides
#218Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#219P2X7, receptor antagonists and uses thereof
#220Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7
#221Pyrazoles for the treatment of obesity and other CNS disorders
#222Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
#223N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
#224Hexahydro-cyclooctyl pyrazole cannabinoid modulators
#225Hexahydro-cycloheptapyrazole cannabinoid modulators
#226Inhibitor of protein modification products formation
#2272-or 3-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
#228Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
#2294-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments
#230Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
#231Non-steroidal antiandrogens
#232Pyrazolones as 11b-HSD1 inhibitors for diabetes
#233Structure of camphor-derived chiral auxiliary and method for forming the same
#234Benzene, pyridine, and pyridazine derivatives
#235Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
#236Charge transport materials having a nitrogen-containing-heterocycle hydrazone group
#237Fused indazole compounds
#238Selective non-steroidal glucocorticoid receptor modulators
#239Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
#240Tricyclic pyrazole kinase inhibitors
#241New indazole and indolone derivatives and their use pharmaceuticals
#242Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
#2431h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
#244Substituted pyrazolyl compounds for the treatment of inflammation
#245Quinazolinyl compounds as inhibitors of potassium channel function
#246Octahydro-2-h-naphtho[1,2-f]indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
#247D-homo-17-chlor-16(17)-ene steroids
#248Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
#249Substituted thioacetamides
#250Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
#251Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
#252Pyrrole and pyrazole DAAO inhibitors
#253Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
#254Small molecule inhibitors of necrosis
#255Immobilized N-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
#256Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
#257Cyclooctynes for click chemistry